An α1-AR antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Bunazosin (hydrochloride)

Item No. 45574

Technical Information
Formal Name
1-[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-1H-1,4-diazepin-1-yl]-1-butanone, monohydrochloride
CAS Number
52712-76-2
Synonyms
  • DDQ
  • E-643
Molecular Formula
C19H27N5O3 • HCl
Formula Weight
Purity
≥98%
A solid
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(CCC)N1CCN(CCC1)C2=NC3=C(C=C(C(OC)=C3)OC)C(N)=N2.Cl
InChi Code
InChI=1S/C19H27N5O3.ClH/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19;/h11-12H,4-10H2,1-3H3,(H2,20,21,22);1H
InChi Key
NBGBEUITCPENLJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Bunazosin is an antagonist of the α1-adrenergic receptor (α1-AR; Kd = 0.59 nM).1 It reduces glutamate-induced decreases in viability in primary rat retinal cells when used at concentrations of 1 and 10 µM.2 Ocular instillation of bunazosin (0.01%) prevents phenylephrine- or endothelin-1-induced constriction of retinal arteries in rabbits. It also prevents reductions in refractive error and increases in axial elongation in a mouse model of lens-induced myopia.3 Formulations containing bunazosin have been used in the treatment of glaucoma and ocular hypertension.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hata, F., Kondo, E., Kondo, S., et al. Characteristics of [3H]E-643-binding to alpha adrenoceptors. Japan J. Pharmacol. 32(1), 181-187 (1982).

    2. Hara, H., Ichikawa, M., Oku, H., et al. Bunazosin, a selective α1-adrenoceptor antagonist, as an anti-glaucoma drug: Effects on ocular circulation and retinal neuronal damage. Cardiovasc. Res. 23(1), 43-56 (2005).

    3. Jeong, H., Lee, D., Jiang, X., et al. Topical application of bunazosin hydrochloride suppresses myopia progression with an increase in choroidal blood perfusion. Invest. Ophthalmol. Vis. Sci. 64(14), 15 (2023).